Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 4
2005 5
2006 2
2007 2
2008 2
2009 2
2010 6
2011 8
2012 4
2013 6
2014 12
2015 11
2016 11
2017 12
2018 12
2019 12
2020 6
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

113 results
Results by year
Filters applied: . Clear all
Page 1
Translational biology of osteosarcoma.
Kansara M, Teng MW, Smyth MJ, Thomas DM. Kansara M, et al. Among authors: teng mw. Nat Rev Cancer. 2014 Nov;14(11):722-35. doi: 10.1038/nrc3838. Epub 2014 Oct 16. Nat Rev Cancer. 2014. PMID: 25319867 Review.
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux.
O'Donnell JS, Massi D, Teng MWL, Mandala M. O'Donnell JS, et al. Among authors: teng mwl. Semin Cancer Biol. 2018 Feb;48:91-103. doi: 10.1016/j.semcancer.2017.04.015. Epub 2017 May 2. Semin Cancer Biol. 2018. PMID: 28467889 Review.
Targeting immunosuppressive adenosine in cancer.
Vijayan D, Young A, Teng MWL, Smyth MJ. Vijayan D, et al. Among authors: teng mwl. Nat Rev Cancer. 2017 Dec;17(12):709-724. doi: 10.1038/nrc.2017.86. Epub 2017 Oct 23. Nat Rev Cancer. 2017. PMID: 29059149 Review.
Resistance to PD1/PDL1 checkpoint inhibition.
O'Donnell JS, Long GV, Scolyer RA, Teng MW, Smyth MJ. O'Donnell JS, et al. Among authors: teng mw. Cancer Treat Rev. 2017 Jan;52:71-81. doi: 10.1016/j.ctrv.2016.11.007. Epub 2016 Nov 27. Cancer Treat Rev. 2017. PMID: 27951441 Review.
The Promise of Neoadjuvant Immunotherapy and Surgery for Cancer Treatment.
O'Donnell JS, Hoefsmit EP, Smyth MJ, Blank CU, Teng MWL. O'Donnell JS, et al. Among authors: teng mwl. Clin Cancer Res. 2019 Oct 1;25(19):5743-5751. doi: 10.1158/1078-0432.CCR-18-2641. Epub 2019 Apr 30. Clin Cancer Res. 2019. PMID: 31040150 Free article. Review.
113 results